Daniel E. Freedberg

14.6k total citations · 2 hit papers
111 papers, 4.3k citations indexed

About

Daniel E. Freedberg is a scholar working on Infectious Diseases, Surgery and Gastroenterology. According to data from OpenAlex, Daniel E. Freedberg has authored 111 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Infectious Diseases, 40 papers in Surgery and 32 papers in Gastroenterology. Recurrent topics in Daniel E. Freedberg's work include Clostridium difficile and Clostridium perfringens research (33 papers), Helicobacter pylori-related gastroenterology studies (21 papers) and Gastroesophageal reflux and treatments (20 papers). Daniel E. Freedberg is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (33 papers), Helicobacter pylori-related gastroenterology studies (21 papers) and Gastroesophageal reflux and treatments (20 papers). Daniel E. Freedberg collaborates with scholars based in United States, United Kingdom and Canada. Daniel E. Freedberg's co-authors include Julian A. Abrams, Yu‐Xiao Yang, Benjamin Lebwohl, Timothy C. Wang, Hojjat Salmasian, Yael R. Nobel, Susan Whittier, Jordana T. Bell, Maria-Emanuela Maxan and Matthew Jackson and has published in prestigious journals such as Nature, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Daniel E. Freedberg

110 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Proton pump inhibitors alter the composition of the gut microbiota

2015 627 citations Matthew Jackson, Julia K. Goodrich et al. Gut profile →
The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association

2017 559 citations Daniel E. Freedberg, Yu‐Xiao Yang et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel E. Freedberg United States	31	1.4k	1.3k	1.2k	1.1k	745	111	4.3k
Marcello Candelli Italy	33	1.8k 1.3×	561 0.4×	1.0k 0.9×	959 0.8×	715 1.0×	186	4.1k
Veronica Ojetti Italy	36	1.9k 1.3×	512 0.4×	1.2k 1.0×	1.0k 0.9×	650 0.9×	149	4.2k
Julian A. Abrams United States	42	3.7k 2.7×	770 0.6×	1.4k 1.2×	1.1k 1.0×	711 1.0×	153	6.0k
Marcello Covino Italy	31	1.1k 0.8×	554 0.4×	263 0.2×	553 0.5×	858 1.2×	208	3.5k
Benjamin H. Mullish United Kingdom	33	673 0.5×	1.7k 1.3×	701 0.6×	2.2k 1.9×	1.1k 1.5×	135	3.8k
Man Yee Yung Hong Kong	19	1.4k 1.0×	1.3k 1.0×	789 0.7×	162 0.1×	632 0.8×	33	3.5k
Ilan Youngster Israel	26	390 0.3×	1.7k 1.2×	431 0.4×	1.1k 1.0×	1.1k 1.4×	77	3.4k
Elizabeth C. Verna United States	42	1.9k 1.4×	1.0k 0.8×	268 0.2×	371 0.3×	2.7k 3.6×	185	5.9k
Francesca Romana Ponziani Italy	39	1.0k 0.8×	532 0.4×	280 0.2×	1.8k 1.6×	2.1k 2.9×	178	5.1k
Lyubov Lytvyn Canada	30	592 0.4×	497 0.4×	235 0.2×	512 0.5×	588 0.8×	55	3.1k

Countries citing papers authored by Daniel E. Freedberg

Since Specialization

Citations

This map shows the geographic impact of Daniel E. Freedberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel E. Freedberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel E. Freedberg more than expected).

Fields of papers citing papers by Daniel E. Freedberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel E. Freedberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel E. Freedberg. The network helps show where Daniel E. Freedberg may publish in the future.

Co-authorship network of co-authors of Daniel E. Freedberg

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel E. Freedberg. A scholar is included among the top collaborators of Daniel E. Freedberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel E. Freedberg. Daniel E. Freedberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Park, Heekuk, Kristen Lewis, Zhezhen Jin, et al.. (2025). A phase 2 randomized, placebo-controlled trial of inulin for the prevention of gut pathogen colonization and infection among patients admitted to the intensive care unit for sepsis. Critical Care. 29(1). 21–21. 5 indexed citations

Rainis, Tova, et al.. (2024). Mo1200 NOVEL TONGUE IMAGING TECHNOLOGY HAS THE POTENTIAL TO DETECT COLONIC ADENOMAS: PRELIMINARY RESULTS FROM A TEST DATASET. Gastroenterology. 166(5). S–976. 1 indexed citations

Fan, Weijia, et al.. (2024). Gut colonization with multidrug resistant organisms in the intensive care unit: a systematic review and meta-analysis. Critical Care. 28(1). 211–211. 7 indexed citations

Baldini, Federico, Heekuk Park, Daniel E. Freedberg, et al.. (2023). The Salivary Microbiome and Predicted Metabolite Production Are Associated with Barrett's Esophagus and High-Grade Dysplasia or Adenocarcinoma. Cancer Epidemiology Biomarkers & Prevention. 33(3). 371–380. 7 indexed citations

Sehgal, Priya, John R. Zech, Yael R. Nobel, et al.. (2023). Visceral Adiposity Independently Predicts Time to Flare in Inflammatory Bowel Disease but Body Mass Index Does Not. Inflammatory Bowel Diseases. 30(4). 594–601. 23 indexed citations

Baik, Jung Eun, Li Li, Manish A. Shah, et al.. (2022). Circulating IgA Antibodies Against Fusobacterium nucleatum Amyloid Adhesin FadA are a Potential Biomarker for Colorectal Neoplasia. Cancer Research Communications. 2(11). 1497–1503. 11 indexed citations

Lebwohl, Benjamin, et al.. (2021). Who uses probiotics and why? A survey study conducted among general gastroenterology patients. BMJ Open Gastroenterology. 8(1). e000742–e000742. 4 indexed citations

Varma, Sanskriti, et al.. (2021). A Simple Emergency Department-Based Score Predicts Complex Hospitalization in Patients with Inflammatory Bowel Disease. Digestive Diseases and Sciences. 67(2). 629–638. 4 indexed citations

Blackett, John W., et al.. (2021). Characteristics and Outcomes of Endoscopies before and during the COVID-19 Pandemic in New York. Digestive Diseases. 39(6). 663–672. 4 indexed citations

10.

Nobel, Yael R., Michaela R. Anderson, Lyndon Luk, et al.. (2021). Relationship Between Body Composition and Death in Patients with COVID-19 Differs Based on the Presence of Gastrointestinal Symptoms. Digestive Diseases and Sciences. 67(9). 4484–4491. 8 indexed citations

11.

Munck, Christian, Ravi U. Sheth, Daniel E. Freedberg, & Harris H. Wang. (2020). Recording mobile DNA in the gut microbiota using an Escherichia coli CRISPR-Cas spacer acquisition platform. Nature Communications. 11(1). 95–95. 60 indexed citations

12.

Horvath, Angela, Florian Rainer, Mina Bashir, et al.. (2019). Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis. Scientific Reports. 9(1). 12000–12000. 55 indexed citations

13.

Nobel, Yael R., Erik J. Snider, Daniel E. Freedberg, et al.. (2018). Increasing Dietary Fiber Intake Is Associated with a Distinct Esophageal Microbiome. Clinical and Translational Gastroenterology. 9(10). e199–e199. 48 indexed citations

14.

Cohen, Margot E., et al.. (2017). Prophylaxis for Stress Ulcers With Proton Pump Inhibitors Is Not Associated With Increased Risk of Bloodstream Infections in the Intensive Care Unit. Clinical Gastroenterology and Hepatology. 15(7). 1030–1036.e1. 9 indexed citations

15.

Jackson, Matthew, Julia K. Goodrich, Maria-Emanuela Maxan, et al.. (2015). Proton pump inhibitors alter the composition of the gut microbiota. Gut. 65(5). 749–756. 627 indexed citations breakdown →

16.

Lagana, Stephen M., Daniel E. Freedberg, Suzanne K. Lewis, et al.. (2015). Endoscopic biopsy technique in the diagnosis of celiac disease: One bite or two?. Gastrointestinal Endoscopy. 81(5). 1228–1233. 40 indexed citations

17.

Freedberg, Daniel E., Esi Lamousé‐Smith, Jenifer R. Lightdale, et al.. (2015). Use of Acid Suppression Medication is Associated With Risk forC. difficileInfection in Infants and Children: A Population-based Study. Clinical Infectious Diseases. 61(6). 912–917. 56 indexed citations

18.

Sharaiha, Reem Z., et al.. (2014). Cost-Effectiveness of Chemoprevention with Proton Pump Inhibitors in Barrett’s Esophagus. Digestive Diseases and Sciences. 59(6). 1222–1230. 9 indexed citations

19.

Freedberg, Daniel E., Benjamin Lebwohl, & Julian A. Abrams. (2014). The Impact of Proton Pump Inhibitors on the Human Gastrointestinal Microbiome. Clinics in Laboratory Medicine. 34(4). 771–785. 124 indexed citations

20.

Freedberg, Daniel E.. (2009). To eGFR or not to eGFR: here is an intern's answer. Kidney International. 76(2). 129–130. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact